Viewing Study NCT06854159


Ignite Creation Date: 2025-12-24 @ 2:39 PM
Ignite Modification Date: 2025-12-24 @ 2:39 PM
Study NCT ID: NCT06854159
Status: RECRUITING
Last Update Posted: 2025-09-29
First Post: 2025-02-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy
Sponsor: Joseph Tuscano
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module